Litigation and Administrative Sanction Risks from Dispensing Errors
First written in FY2017. 4 of 5 entries say "Restated". Latest entry: FY2022.
6 other companies' latest entry also says "Restated".
- FY2022RestatedAnnual report
「In our dispensing operations, we work to improve expertise in dispensing procedures and pharmaceutical knowledge and operate under a comprehensive management system to prevent dispensing errors, but」
The risk of litigation and administrative action arising from dispensing errors, together with responses through improvements in expertise and knowledge and management systems, continues to be disclosed. - FY2020RestatedAnnual report
「If a serious dispensing error results in litigation or administrative action, our performance and financial position could be affected.」
The risk of litigation and administrative action arising from dispensing errors continues to be disclosed. - FY2019RestatedAnnual report
「If a serious dispensing error results in litigation or administrative action, our performance and financial position could be affected.」
The risk of litigation and administrative action arising from dispensing errors continues to be disclosed. - FY2018RestatedAnnual report
「If a serious dispensing error results in litigation or administrative action, our performance and financial position could be affected.」
The risk of litigation and administrative action arising from dispensing errors continues to be disclosed. - FY2017First statedAnnual report
「If a serious dispensing error results in litigation or administrative action, our performance and financial position could be affected.」
While preventing dispensing errors through improvements in dispensing expertise and pharmaceutical knowledge and through our management systems, we disclose the possibility of serious errors as a risk.